marketing for medical practices, hipaa compliant marketing, healthcare marketing compliance

Medical Practice Marketing When the Platforms Won’t Let You Say the Thing

Two constraints shape medical practice marketing. Google and Meta restrict what you can say: a condition, a prescription, a treatment outcome. HIPAA restricts what you can know about who you say it to. Practices that grow anyway build on what patients search before a diagnosis, with landing pages that pass review and still sound like a physician.

Most medical practice marketing fails at ad review, not at strategy. The practice knows what it treats, and the platform will not let it say so the way a retailer would. The data rules sit underneath that, and most ad tooling trips them without anyone noticing.

Everything below is about building marketing for a medical practice around that constraint instead of arguing with it. The constraint is real, it is getting tighter, and it is also where a well-run practice separates from the rest.

Why do Google and Meta reject medical practice marketing ads?

Google’s Healthcare and medicines policy restricts prescription drug terms in ad copy, landing pages, and keywords. In the United States, a practice uses those terms for promotion only after certification through LegitScript and Google. Even certified campaigns run as “Eligible (limited)” and serve only in approved locations.

Google also restricts before-and-after imagery for medical procedures and prohibits health claims the advertiser cannot substantiate. A clinic that writes the way it talks to patients trips both rules in one headline.

Two more Google rules catch practices by surprise. Stem cell, regenerative, and other experimental treatments fall under a separate speculative-medicine policy with its own limits. A practice offering virtual visits counts as a telemedicine provider and needs certification before any ad points at a telehealth page.

Meta polices the reader more than the product. Its Personal Attributes policy forbids any ad that asserts or implies knowledge of a person’s medical condition. “Struggling with low energy after 40?” implies the condition, and the ad is disapproved before a patient sees it.

Meta also treats health and wellness as a sensitive category. Since January 2025, that has limited which conversion events those advertisers optimize toward. The practice loses the signal that makes paid social efficient for everyone else.

The pattern holds on both platforms. The words a clinic needs most are the ones the review system was built to catch. That is an uncomfortable fact to build a campaign around, and the only one that matters.

Enforcement is mostly automated. Image scanners read the text and bodies in creative, language models read the destination page, and both re-scan on a schedule. A campaign runs clean for three weeks, a re-scan or a user report trips it, and a human reviewer sees the whole account at once.

Enforcement has tightened each year since 2024, and the direction is one way. A campaign that cleared review in 2025 is not evidence that it clears review in 2027.

What is adjacent-intent targeting?

Adjacent intent is what a patient searches before they have a diagnosis. Nobody searches for a treatment protocol first. They search for the thing that is wrong.

Three categories carry most of it. Symptoms: fatigue, broken sleep, weight that will not move, brain fog. Lifestyle markers: performance at the gym, energy at work, recovery that takes longer than it used to.

The third is local. Patients type the city and the problem, not the therapy. “Doctor for fatigue in Bend” is a real query, and no policy restricts it.

None of those terms is restricted, because none of them names a drug or asserts a condition. They are what the patient is already typing. A campaign built on them reaches the same person the restricted term would have reached, earlier in the decision, with no flag.

It is also better medical practice marketing. A patient searching a symptom has not chosen a provider or a treatment. The practice that answers the symptom question gets to frame the diagnosis conversation.

The same logic runs the organic side. Symptom-led blog content and a Google Business Profile that lists the problems the practice evaluates rank on terms paid cannot touch. Local pages built around “physician in [city] for [symptom]” do the same.

Paid buys the first visit; organic earns the second and third.

The discipline is in what gets left out. Adjacent intent works only when the keyword list, the ad copy, and the landing page all stay on the patient’s side of the diagnosis. One restricted term in any of the three, and the review reads the whole set as restricted.

The rewrite is usually small. The intent underneath it is the same.

RestrictedAdjacent
Names the therapy or the prescriptionNames the symptom the patient feels
“Do you have low T?” (asserts a condition)“Tired by 3 p.m. most days? A physician can tell you why.” (describes an experience)
Before-and-after transformation imagePhysician at a desk, lab panel on screen
“Clinic for [condition] in Bend”“Bend physician for fatigue, sleep, and energy”
Guaranteed outcome in the headlineWhat the evaluation covers, in the headline

Each row on the right reaches the same patient as the row on the left. It reaches them earlier, and it survives review.

How do you write a landing page that passes review and still converts?

In medical practice marketing, platforms review the destination as closely as the ad. The landing page is the second place a campaign fails, and usually the more expensive one.

Lead with the problem the patient searched for, in the words they used. Describe the evaluation, not the prescription: what gets tested, who reads the results, what a first appointment involves. That is the content Google’s quality systems reward and the content an uncertain patient needs.

Name the physician. Credentials, specialty, years in practice, and a photograph that looks like a doctor’s office rather than a stock library. For health content, Google weighs who is speaking as heavily as what is said.

Keep claims to what the practice does, not what the patient will become. “Comprehensive lab panel reviewed by a physician” passes. “Feel 25 again” fails on both platforms and would not survive a state medical board either.

Give the page one action and make it clinical. Book an evaluation. Request a consultation.

The form matters as much as the button. Checkboxes for specific treatments or conditions turn an intake form into a flagged page on the next crawl. Use a neutral multi-step intake, and route to a general physician evaluation rather than a named therapy consultation.

Appointment language reads as a practice. Sales language reads as a supplement company, and reviewers on both platforms know the difference.

Structure the page for the way search now reads it. A short answer to the symptom question in the first paragraph, then question-based subheads that match what patients type. FAQ and physician schema in the code, so Google and the AI answer engines attribute the content to a named clinician.

The brand standard matters as much as the policy standard. A page passes review and still sounds like a wellness influencer more often than practices realize. Patients considering a physician-led practice notice, and so do the physicians that practice wants referrals from.

What does HIPAA-compliant marketing actually require?

HIPAA governs protected health information, or PHI, not advertising. It does not decide whether an ad gets approved; the platforms do that. What it decides is what a practice is allowed to know about the people it advertises to.

Modern ad tooling creates PHI without anyone deciding to.

A retargeting pixel on a patient portal page ties an identifiable person to a care relationship. That is PHI. A lookalike audience seeded from a patient list is PHI.

Server-side tracking is not the way around it. Sending hashed emails or phone numbers through Meta’s Conversions API alongside a health-related page URL is the same disclosure by a different route. Meta’s own terms prohibit it.

The HHS Office for Civil Rights has published guidance on tracking technologies since 2022 and treats this as a HIPAA matter. A 2024 federal court ruling narrowed it for public pages, but not for patient portals. Plaintiffs’ firms and state attorneys general scan medical sites for pixels on condition-specific pages, and the suits are filed from the scan.

A testimonial that names a patient and a treatment needs written authorization, not a verbal yes at the front desk. A marketing email to existing patients about a third-party product needs authorization too.

Three rules cover most of it. Tracking tools stay off every page a logged-in patient reaches, and the public site runs on a separate domain or subdomain from the portal. Patient lists never go to an ad platform without authorization.

Every vendor that touches patient data signs a business associate agreement before it touches anything. Most ad platforms will not sign one, which settles the question of what they get.

Compliant marketing for a medical practice targets the public, not the patient base. That lines up with adjacent intent. The people a practice wants to reach have not become patients yet, so there is no PHI in reaching them.

One more place PHI leaks: review replies. A response that thanks a named reviewer for choosing the practice for their treatment confirms a care relationship in public. The reply thanks them for the feedback and stops there.

When does compliance cost more than it saves?

Compliance has a visible cost: fewer keywords, slower approvals, a smaller conversion toolkit. The cost of skipping it is invisible until it is total.

Platform enforcement escalates. A disapproved ad becomes a pattern of disapprovals. The pattern becomes a restricted account.

A restricted account becomes a suspended one, and suspensions follow the business, not the campaign. Opening a new account under the same practice name is itself a violation.

A practice that has lost its Google or Meta account has lost the channel. Reinstatement takes months when it happens at all, and in the meantime a competitor is buying the symptom searches.

Regulatory cost sits above that. HIPAA penalties scale with negligence. State medical boards police advertising claims directly, and a complaint from a competitor is enough to open a review.

Compliance costs more than it saves in one case only: when it arrives as a legal review after the campaign is built. Build it in from the first keyword, and it costs almost nothing. Bolt it on after launch, and it costs the launch.

There is a quieter cost on the other side. Practices that over-correct run no paid media at all and leave the symptom searches to a competitor with a compliance process. Restricted is not the same as closed, and the searches are still there for whoever shows up prepared.

Who should run marketing for a medical practice?

Whoever runs it needs three things at once. The platform rules, the regulatory rules, and the judgment to write a brand that sounds like a physician inside both. Most teams have one of the three.

A general agency knows the platforms and learns the health rules on the practice’s budget. In-house staff know the practice and lack the hours to track policy changes that arrive quarterly. AI tools generate volume fast and have no idea what Meta will flag.

Savy has done this from zero. A physician-led health practice came to us with a vision and no brand behind it.

We named it, built the brand and the site, and launched it into one of the most restricted advertising categories there is. It is scaling now.

That is the shape of medical practice marketing that works. The brand reads as a clinic, and the campaign reads as a patient, and a reviewer finds nothing in between to flag.

The practices that struggle are not the ones with weak offers. They are the ones whose marketing was built for a category that is allowed to say anything, then pointed at a category that is not.

Healthcare marketing with Savy

Savy builds and runs marketing for physician-led practices, health tech companies, and other brands that advertise under restrictions. The work covers brand strategy and naming, and compliance-aware paid media on Google and Meta. It covers websites with YMYL content written to E-E-A-T standards, local SEO, content programs, segmented email, and physician referral strategy.

AI handles the production volume. Savy has been an agency for more than twenty years, and the people doing the work have been at it longer than that. They decide what is credible, compliant, and worth a physician’s name. Savy is a Premier Google Partner in the top 3 percent of agencies.

The offices are in Bend, Oregon, and Santa Barbara, California. The clients are not. Savy serves brands and leaders nationwide, and international brands have been part of the roster for years.

The full healthcare offer is at savyagency.com/healthcare-marketing-agency/.

Request a healthcare marketing audit. Savy reads your current campaigns, landing pages, and tracking against Google policy, Meta policy, and HIPAA. You get back what is flagged, what is exposed, and which patient searches you are not buying.

Recent Posts

Marketing Budget Allocation for 2027: The Budget Holds, the Work Moves

Retainers hold, value goes up, and deliverables pivot. Production takes a fraction of the time it did, so the money inside a 2027 marketing budget moves to the two things […]

SaaS Marketing Strategy: What Actually Drives Pipeline in 2026

SaaS is one of the most crowded categories in tech. Dozens of companies often solve the same problem with comparable feature sets and comparable pricing tiers. Buyers have endless options […]

Marketing for Healthtech Startups: From Launch to Scale

Healthtech founders carry a heavier marketing load than most. You are asking people to trust you with their health or their data. That trust has to be earned long before […]

AI-Powered Google Ads: How Top 3% Partners Use Machine Learning

Google Ads has always rewarded the brands that stay ahead of the platform’s capabilities. In 2026, that means knowing how to leverage machine learning and knowing when to override it. […]

The Strategic Naming Process: How Great Brand Names Are Built

A brand name is one of the most consequential decisions a business will ever make. It shapes first impressions and carries emotional weight. It becomes the single word (or two) […]